首頁 > 市場調查報告書 > 製藥

骨疾病

市場調查報告書

商品編碼

2126671

膝骨關節炎市場：依藥物類型、給藥途徑、通路及地區分類

Knee Osteoarthritis Market, By Drug Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年08月10日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年膝骨關節炎市場規模預計為92.284億美元，預計2033年將達到198.423億美元。預計2026年至2033年，該市場將以11.6%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	92.284億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	11.60%	2033年市場規模預測：	198.423億美元

膝骨關節炎（OA）是一種進行性性關節疾病，它會逐漸破壞膝關節軟骨，導致疼痛、僵硬、腫脹和活動範圍受限。膝骨關節炎是世界上最常見的肌肉骨骼疾病之一，其發生率因老化、肥胖、運動傷害和久坐的生活方式等因素而不斷上升。

骨關節炎市場涵蓋多個細分領域，包括關節疼痛和發炎藥物、關節內注射和黏彈性置換、矯正器具、物理治療以及各種外科手術治療，例如全膝關節關節重建。在醫療保健支出不斷成長和整形外科醫學持續進步的推動下，人們對再生醫學的興趣日益濃厚，例如富血小板血漿（PRP）、幹細胞療法和骨關節炎疾病修飾療法（DMOADs）。

市場動態

全球膝骨關節炎市場成長的主要促進因素包括人口老化、肥胖盛行率上升以及關節損傷發生率增加，這些因素共同導致需要長期治療的患者群體不斷擴大。此外，人們對早期診斷的認知不斷提高、先進影像技術的普及以及對緩解疾病修飾骨關節炎治療藥物（DMOADs）、生物製藥和微創療法的投資增加，也進一步推動了市場成長。

然而，骨關節炎市場面臨許多限制因素，包括先進療法和全膝關節關節重建手術的高成本、開發中國家保險報銷範圍有限，以及缺乏廣泛批准的緩解疾病療法。儘管如此，幹細胞和富血小板血漿（PRP）療法等再生醫學技術的日益普及，以及人工智慧診斷和數位健康解決方案的採用，將為骨關節炎市場帶來新的成長機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數創建了全球膝骨關節炎市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，行銷負責人和企業經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球膝關節骨關節炎市場」報告旨在為該行業的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球膝骨關節炎市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

公司簡介
- Pfizer Inc.
- Eli Lilly and Company
- Sanofi
- Bayer AG
- GSK plc
- Novartis AG
- AbbVie Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- Anika Therapeutics, Inc.

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9913

Knee Osteoarthritis Market is estimated to be valued at USD 9,228.4 Mn in 2026 and is expected to reach USD 19,842.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 9,228.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.60%	2033 Value Projection:	USD 19,842.3 Mn

Knee osteoarthritis (OA) is a progressive joint disease that slowly destroys the knee's cartilage causing pain, stiffness, swelling and limited movement. Knee osteoarthritis is one of the most common musculoskeletal diseases in the world and its prevalence is increasing due to ageing populations, obesity, sports injuries and sedentary lifestyles.

The knee osteoarthritis market is characterized by multiple segments such as medications for joint pain and inflammation, joint injections and visco supplements, orthotic aids, physiotherapies and a wide spectrum of surgical knee osteoarthritis treatment including knee replacement surgery. The market is witnessing growing interest in regenerative therapies, including platelet-rich plasma (PRP), stem cell therapies, and disease-modifying osteoarthritis drugs (DMOADs), supported by rising healthcare expenditure and continuous advancements in orthopedic care.

Market Dynamics

The global knee osteoarthritis market is driven by growing aging population, increasing prevalence of obesity, and growing incidence of joint injuries leading to a larger patient pool that needs long-term treatment. Growing awareness for early diagnosis, improving access to cutting-edge imaging technologies, and increasing investments in disease-modifying osteoarthritis drugs (DMOADs), biologics, and minimally invasive therapies are further contributing to the market growth.

However, a number of constraints are present in the market, such as high cost of advanced therapies and knee replacement procedures, limited reimbursement in developing countries, and lack of widely approved disease-modifying treatments. Nevertheless, expanding use of regenerative medicine modalities like stem cell and platelet-rich plasma (PRP) therapies, coupled with the implementation of AI-enabled diagnostics and digital health solutions will offer new opportunities for growth in knee osteoarthritis market.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global knee osteoarthritis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Eli Lilly and Company, Sanofi, Bayer AG, GSK plc, Novartis AG, AbbVie Inc., Merck & Co., Inc., Johnson & Johnson, and Anika Therapeutics, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global knee osteoarthritis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global knee osteoarthritis market

Market Segmentation

Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
Hyaluronic acid
Non-steroidal anti-inflammatory drugs (NSAIDs)
Analgesics
Corticosteroid
Others
Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
Oral
Parenteral
Others
Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Pfizer Inc.
Eli Lilly and Company
Sanofi
Bayer AG
GSK plc
Novartis AG
AbbVie Inc.
Merck & Co., Inc.
Johnson & Johnson
Anika Therapeutics, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Knee Osteoarthritis Market, By Drug Type
- Global Knee Osteoarthritis Market, By Route of Administration
- Global Knee Osteoarthritis Market, By Distribution Channel
- Global Knee Osteoarthritis Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Industry Trends

4. Global Knee Osteoarthritis Market, By Drug Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hyaluronic acid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Non-steroidal anti-inflammatory drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Corticosteroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Knee Osteoarthritis Market, By Route of Administration, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Knee Osteoarthritis Market, By Distribution Channel, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Knee Osteoarthritis Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Company Profile
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Anika Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies